(Q33597090)

English

eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

diabetic nephropathy

1 reference

based on heuristic

inferred from title

Takahiko Nakagawa

5

object named as

Takahiko Nakagawa

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Tomoki Kosugi

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Marcelo Heinig

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Takahiro Nakayama

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Seiichi Matsuo

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

30 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

176

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

619-629

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Renal and retinal effects of enalapril and losartan in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

The incidence and implications of aldosterone breakthrough

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Aldosterone in the development and progression of renal injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Differential regulation of VEGF by TGF-beta and hypoxia in rat proximal tubular cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Vascular defect beyond the endothelium in type II diabetic patients with overt nephropathy and moderate renal insufficiency.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Regression of microalbuminuria in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Antihypertensive Drug Utilization in Hypertensive Veterans With Complex Medication Profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

ACE-inhibitor use and the long-term risk of renal failure in diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Baroreflex sensitivity in rabbits during the development of experimental renal hypertension and medial sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of ACE inhibitors as renoprotective agents in Medicaid patients with diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sympathetic baroreceptor responses after chronic NG-nitro-L-arginine methyl ester treatment in conscious rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mouse models of diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2353/AJPATH.2010.090578

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33597090&oldid=1950495371"